Cargando…

Beta-adrenergic signaling, a novel target for cancer therapy?

Detalles Bibliográficos
Autor principal:	Schuller, Hildegard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2010
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248132/ https://www.ncbi.nlm.nih.gov/pubmed/21317444

Ejemplares similares

Beta-Adrenergic gene therapy for cardiovascular disease
por: Eckhart, Andrea D, et al.
Publicado: (2000)

Cooperative Regulation of Non-Small Cell Lung Carcinoma by Nicotinic and Beta-Adrenergic Receptors: A Novel Target for Intervention
por: Al-Wadei, Hussein A. N., et al.
Publicado: (2012)

Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell lines
por: Plummer, Howard K, et al.
Publicado: (2004)

Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma
por: Dickerson, Erin B., et al.
Publicado: (2015)

The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms
por: quốc Lu’o’ng, Khanh vinh, et al.
Publicado: (2012)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression
por: Zhao, Yicheng, et al.
Publicado: (2019)

At the Crossroads of Cardiac Beta-Adrenergic Receptor Signaling and Myocardial Glucose Metabolism
por: Kereliuk, Stephanie M., et al.
Publicado: (2023)

Beta adrenergic antagonists and antianginal drugs
por: Stever, Lindsey M., et al.
Publicado: (2021)

Novel mechanism of resistance to targeted therapies in lung cancer
por: Wang, Walter, et al.
Publicado: (2018)

Biomarker Identification in Breast Cancer: Beta-Adrenergic Receptor Signaling and Pathways to Therapeutic Response
por: Kafetzopoulou, Liana E., et al.
Publicado: (2013)

Beta-adrenergic receptors are expressed across diverse cancers
por: Rains, Steven L., et al.
Publicado: (2017)

Beta-Adrenergic Blockade in Critical Illness
por: Bruning, Rebecca, et al.
Publicado: (2021)

β(2 )adrenergic agonists in acute lung injury? The heart of the matter
por: Lee, Jae W
Publicado: (2009)

LBMON186 Beta-agonist Profiling Reveals Novel Biased Signaling Phenotypes For The Beta 2-adrenergic Receptor With Implications In The Treatment Of Asthma
por: Pascali, Francesco D, et al.
Publicado: (2022)

Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy
por: Icard, Philippe, et al.
Publicado: (2018)

Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy
por: Ramsell, Stuart, et al.
Publicado: (2022)

INCREASED BETA2-ADRENERGIC RECEPTOR SIGNALING ENHANCES PROGRESSION OF HEPATOCELLULAR CARCINOMA
por: Pizzini, Jason, et al.
Publicado: (2019)

Beta adrenergic blockade reduces utilitarian judgement
por: Sylvia, Terbeck, et al.
Publicado: (2013)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

The Clinical Pharmacology of Beta Adrenergic Blocking Drugs
por: McDevitt, D. G., et al.
Publicado: (1976)

The Role of Beta-Adrenergic Receptors in Depression and Resilience
por: Zhang, Hongxing, et al.
Publicado: (2022)

Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
por: Davidson, Michael H.
Publicado: (2015)

Broad-Scale Phosphoprotein Profiling of Beta Adrenergic Receptor (β-AR) Signaling Reveals Novel Phosphorylation and Dephosphorylation Events
por: Chruscinski, Andrzej J., et al.
Publicado: (2013)

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)

The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer
por: Montoya, Alexa, et al.
Publicado: (2019)

Targeting of Beta Adrenergic Receptors Results in Therapeutic Efficacy against Models of Hemangioendothelioma and Angiosarcoma
por: Stiles, Jessica M., et al.
Publicado: (2013)

Alpha and beta adrenergic receptors modulate keratinocyte migration
por: Yang, Hsin-ya, et al.
Publicado: (2021)

β‐Adrenergic signaling in skin cancer
por: Batalla‐Covello, Jennifer, et al.
Publicado: (2022)

CDK7 Mediates the Beta-Adrenergic Signaling in Thermogenic Brown and White Adipose Tissues
por: Ji, Honglei, et al.
Publicado: (2020)

Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure
por: Perez, Dianne M.
Publicado: (2021)

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer
por: Krönig, Malte, et al.
Publicado: (2017)

Cancer biomarkers and targeted therapies
por: Shen, Zhiyuan
Publicado: (2013)

Harnessing Wnt signaling as a targetable therapy in epithelial ovarian cancer
por: Wall, Jaclyn A., et al.
Publicado: (2020)

Body‐weight‐independent glucose‐lowering effect of the β3‐adrenergic receptor agonist mirabegron in humans
por: Waki, Hironori, et al.
Publicado: (2021)

Morphology of astroglial cells is controlled by beta-adrenergic receptors
Publicado: (1987)

Beta-Adrenergic Modulation of Tremor and Corticomuscular Coherence in Humans
por: Baker, Mark R., et al.
Publicado: (2012)

The Principles of Ligand Specificity on beta-2-adrenergic receptor
por: Chan, H. C. Stephen, et al.
Publicado: (2016)

Dissecting Beta-Adrenergic Receptors: The Sum of Many Parts
por: Port, J. David
Publicado: (2023)

Beta(1)-Adrenergic Receptor Cleavage and Regulation by Elastase
por: Zhu, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ni3f292tpq3lbshud2j0pipe5m